Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas

Annals of Diagnostic Pathology

Volumn 4, Issue 4, 2000, Pages 218-227

  Prayson, Richard A ^a   Mohan, Dasarahally S ^a   Song, Priscilla ^a   Suh, John H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Anaplastic oligodendroglioma; Glioma; MIB 1; Oligodendroglioma; p53

Indexed keywords

MONOCLONAL ANTIBODY KI 67; NITROSOUREA DERIVATIVE; PROCARBAZINE; PROTEIN P53; VINCRISTINE; CELL NUCLEUS ANTIGEN; KI 67 ANTIGEN; NUCLEAR PROTEIN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ANAPLASTIC CARCINOMA; ANTIBODY LABELING; ARTICLE; BRAIN TUMOR; CANCER GRADING; CANCER SURVIVAL; CELL DENSITY; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION FUNCTION; FEMALE; FOLLOW UP; HISTOLOGY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MITOSIS; OLIGODENDROGLIOMA; PRIORITY JOURNAL; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MITOSIS INDEX; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; ANTIGENS, NUCLEAR; CHILD; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; MITOTIC INDEX; NUCLEAR PROTEINS; OLIGODENDROGLIOMA; PROGNOSIS; RETROSPECTIVE STUDIES; SUPRATENTORIAL NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033624663     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1053/adpa.2000.8124     Document Type: Article

References (40)

1. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization
2. Deletion mapping of chromosome 19 in human gliomas
3. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p
4. Allelic status of chromosome 1 in neoplasms of the nervous system
5. Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of tumor glioma
6. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas
7. Grading astrocytomas. A simple and reproducible method
8. Immunohistology of lymphoproliferative disorders
9. Immunohistochemical assessment of proliferative activity in adrenocotical neoplasms
10. Clinicopathologic correlation in the oligodendroglioma
11. Oligodendroglioma: A comparison of two grading systems
12. Oligodendroglioma. Histologic evaluation and prognosis
13. Grading of oligodendrogliomas
14. Oligodendroglioma. The Rotterdam-Dijkzigt experience
15. Oligodendroglioma: An analysis of 63 cases
16. A clinicopathological study of 323 patients with oligodendrogliomas
17. Oligodendrogliomas: The Mayo Clinic experience
18. Cerebral oligodendroglioma: Prognostic factors and life history
19. Statistical analysis of clinicopathological features, radiotherapy, and survival in 170 cases of oligodendroglioma
20. Intratumoral histologic heterogeneity of gliomas. A quantitative study
21. Oligodendrogliomas: Reproducibility of grading parameters
22. Improving diagnostic accuracy and intraobserver concordance in the classification and grading of primary gliomas
23. A clinicopathologic study of 30 cases of oligoastrocytoma including p53 immunohistochemistry
24. Ki-67 immunoreactivity in human central nervous system tumors: A study with MIB-1 monoclonal antibody on archival material
25. Prognostic significance of proliferating cell nuclear antigen (PCNA) expression in gliomas
26. Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas
27. The prognostic significance of Ki-67 labeling indices for oligodendrogliomas
28. Prognostic implications of histopathological, immunohistochemical and clinical features of oligodendrogliomas: A study of 89 cases
29. Proliferation and cell death in oligodendrogliomas
30. Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms
31. Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index
32. Expression of p53 in oligodendrogliomas
33. Molecular genetic analysis of non-astrocytic gliomas
34. p53 Mutations in nonastrocytic human brain tumors
35. Immunocytochemical detection of p53 in human gliomas
36. Frequency of p53 tumor suppressor gene mutations in human primary brain tumors
37. p53 Protein expression in central nervous system tumors: An immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies
38. Paraffin section p53 protein immunohistochemistry in neuroectodermal tumors